Live feed
Filing
SC 13D/A
SC 13D/A0001178913-14-002789·Bio-Cell Ltd
Schedule 13D ownership disclosure
Protalix BioTherapeutics, Inc.
Security class unavailable · CUSIP: 74365A101
Event date: 2014-08-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-14-002789
- Form type
- SC 13D/A
- Filer
- Bio-Cell Ltd
- CIK
- CIK 1385114
- Filed
- Aug 28, 2014
- Reporting period
- Aug 26, 2014
- Description
- Schedule 13D beneficial ownership